DNTTIP2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.977200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.922600E-01
Normal-vs-Stage2
5.764000E-01
Normal-vs-Stage3
5.486200E-01
Normal-vs-Stage4
7.616900E-03
Stage1-vs-Stage2
4.370000E-01
Stage1-vs-Stage3
4.457000E-01
Stage1-vs-Stage4
1.861780E-03
Stage2-vs-Stage3
1.609400E-01
Stage2-vs-Stage4
4.398500E-03
Stage3-vs-Stage4
1.113950E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.074400E-01
Normal-vs-AfricanAmerican
5.869400E-01
Normal-vs-Asian
7.781600E-01
Caucasian-vs-AfricanAmerican
7.827800E-01
Caucasian-vs-Asian
6.863800E-01
AfricanAmerican-vs-Asian
6.628000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.091600E-01
Normal-vs-Female
4.762800E-01
Male-vs-Female
2.514800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.838200E-01
Normal-vs-Age(41-60Yrs)
2.647000E-01
Normal-vs-Age(61-80Yrs)
7.957000E-01
Normal-vs-Age(81-100Yrs)
6.576200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.238400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.179200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.826600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.137600E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.506170E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.835000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.524200E-01
Normal-vs-Daily Drinker
7.754000E-01
Normal-vs-Weekly Drinker
9.402800E-01
Normal-vs-Occasional Drinker
9.917600E-02
Normal-vs-Social Drinker
4.550600E-01
Non Drinker-vs-Daily Drinker
4.485200E-01
Non Drinker-vs-Weekly Drinker
7.976000E-01
Non Drinker-vs-Occasional Drinker
1.657300E-03
Non Drinker-vs-Social Drinker
2.002000E-01
Daily Drinker-vs-Weekly Drinker
7.270000E-01
Daily Drinker-vs-Occasional Drinker
3.126000E-02
Daily Drinker-vs-Social Drinker
6.495400E-01
Weekly Drinker-vs-Occasional Drinker
2.446000E-02
Weekly Drinker-vs-Social Drinker
4.333600E-01
Occasional Drinker-vs-Social Drinker
5.614300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.567600E-01
Normal-vs-Grade 2
7.559600E-01
Normal-vs-Grade 3
7.834600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.429100E-04
Grade 1-vs-Grade 3
8.995600E-03
Grade 1-vs-Grade 4
9.567600E-01
Grade 2-vs-Grade 3
5.312600E-01
Grade 2-vs-Grade 4
7.559600E-01
Grade 3-vs-Grade 4
7.834600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.853400E-01
Normal-vs-NonDiabetic
6.247000E-01
Diabetic-vs-NonDiabetic
5.918800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.967400E-01
Normal-vs-NoPancreatitis
6.539400E-01
Pancreatitis-vs-NoPancreatitis
5.341400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.336600E-01
Normal-vs-N1
5.510600E-01
N0-vs-N1
7.082200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.381900E-03
Normal-vs-TP53-NonMutant
6.344200E-01
TP53-Mutant-vs-TP53-NonMutant
1.681750E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
